We are proud to announce that Ilios Therapeutics has been selected as one of the 14 biotech companies to take part to the StartUp Health's Global Alzheimer's Moonshot. Launched this year with support from Gates Ventures and Alzheimer's Drug Discovery Foundation, we are confident that the program will help advance our development towards transformational therapeutics for patients suffering from devastating neurodegenerative diseases. Congrats to the other companies selected: only as a community can we make meaningful steps towards putting an end to Alzheimer's and other neurodegenerative diseases.
🎉 We are thrilled to announce the first 14 members to join StartUp Health’s Alzheimer's Moonshot Community, which was launched this year with support from Gates Ventures and the Alzheimer's Drug Discovery Foundation (ADDF). These inspiring founders and researchers span the spectrum from early detection to treatment to caregiver support and we’re already seeing the power of collaboration as we bring the community together. Meet them here ➡️ https://ow.ly/vlEi50RPqQC #AlzMoonshot #Alzheimers #HealthTransformers #HealthMoonshot ADmit Therapeutics, ALZpath Inc., C. Light Technologies, Inc., Ilios Therapeutics, Kernel, MindAhead, Moneta Health, Neurosteer, RetiSpec, Sinaptica Therapeutics, Stem Pharm, TELL Toolkit, ToxGenSolutions BV (TGS), Zinnia